Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
How to make an oligodendrocyte.
[Driving ability with multiple sclerosis.]
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica.
Systemic Injection of Low-Dose Lipopolysaccharide Fails to Break down the Blood-Brain Barrier or Activate the TLR4-MyD88 Pathway in Neonatal Rat Brain.
Spiritual wellbeing and perceived uncertainty in patients with multiple sclerosis in south-east Iran.
Targeting molecules to medicine with mTOR, autophagy, and neurodegenerative disorders.
Certified occupational therapy assistants.
Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
A diagnostic challenge in a young woman with intractable hiccups and vomiting: a case of neuromyelitis optica.
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.
Curcumin protects axons from degeneration in the setting of local neuroinflammation.
Secondary Health Conditions in Individuals With Multiple Sclerosis: A Cross-Sectional Web-Based Survey Analysis.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease.
Diffusion-weighted imaging and demyelinating diseases: new aspects of an old advanced sequence.
Response to IV immunoglobulin in a case of osmotic demyelination syndrome.
Pages
« first
‹ previous
…
431
432
433
434
435
436
437
438
439
…
next ›
last »